ABT vs HIND · P/E 25, rev $44.33B vs rev $58.5K
Abbott Laboratories (ABT) versus Vyome Holdings, Inc. (HIND) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported HIND revenue for 2026-06-30 was $58.5K. Net income was -$1.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. HIND currently screens at market cap $16.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. HIND currently screens at market cap $16.1M.
Not investment advice. Open the ABT and HIND stock pages for the full models.
Not investment advice.